Clinical Trial Update: Effect of DPP4 Inhibition on Growth Hormone Secretion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessed whether DPP-4 inhibition influences growth hormone secretion in adults with obesity; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• DPP-4 inhibitors

Snippet

Sponsor: Vanderbilt University | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2018-05-29